Ryan Kaczka

Ryan Kaczka is a seasoned private equity investor, investment banker, and operator with a specialization in initial public offerings, leveraged buyouts, mergers and acquisitions, and de-novo companies. With a primary focus on behavioral health, Ryan also spearheads investments in digital health, biotechnology, pharmaceuticals, and banking. With extensive experience in operations and leadership, he has served as CEO, COO, and board member of numerous companies. In 2018, he was recognized as the Tampa Spotlight CEO and named NJBIZ's 2023 Healthcare Innovator of the Year.

Mr. Kaczka is a prominent figure on various boards, including portfolio companies, the Rutgers University Center for Addiction Studies, the White House/ONDCP Opioid Litigation Abatement Advisory, an international bank, and an international healthcare non-profit. He also serves as a personal advisor to numerous federal, state, and local leaders, including Senators, Congressmen, Committees, Governors, and Department leaders. With a passion for Muay Thai fighting, astrophysics, and advocating for national healthcare and banking reform, Mr. Kaczka brings a unique perspective to his work in the field. His expertise and accomplishments make him the go-to choice for private equity and M&A expertise.

Robert D’Annibale is Vice President of Growth & Corporate Development at Crossroads Treatment Centers, where he leads growth strategy, mergers and acquisitions, business development, marketing, and community engagement. Since joining Crossroads, he has helped drive the organization’s expansion through strategic acquisitions and integration efforts that have increased access to addiction treatment services across multiple states.

Prior to Crossroads, Robert served as Head of Corporate Strategy & Development at Forge Health, leading corporate strategy, M&A, business development, and growth initiatives. Earlier in his career, he worked in healthcare investment banking at Jefferies, advising healthcare organizations on mergers and acquisitions and strategic transactions.

Robert holds a B.A. in Economics with a Minor in Financial Economics from Johns Hopkins University and regularly speaks on healthcare growth strategy, behavioral health, and M&A.

Geoff Nudd is CEO and Co-Founder of Anonymous Health, the enterprise AI company helping behavioral health organizations expand access to care, improve admissions performance, and strengthen the patient experience. Under his leadership, Anonymous Health now serves more than 30% of the largest providers in behavioral health, helping them improve how patients find and enter care while supporting stronger operational outcomes.

Working alongside Dr. Angie Chen, National Medical Director and Clinical Professor of Addiction Medicine at Stanford University, Geoff is advancing the responsible use of AI in behavioral healthcare, with a focus on supporting patients and the organizations that serve them.

Previously, Geoff co-founded ClearCare, which became the system of record for more than 4,000 home care organizations and over one million caregivers.

Dr. Carrie Singer is a licensed psychologist, healthcare entrepreneur, four-time Inc. 5000 founder, and former CEO of a multi-site, family office-backed behavioral health platform that grew to more than 150 clinicians across ten locations.

Following the transaction, Carrie remained actively involved in platform growth, helping source, negotiate, and integrate acquisitions, improve payer economics, and scale operations across portfolio companies. Having participated in deals as a founder, operator, seller, buyer, board member, and minority equity holder, she brings a unique perspective on how value is created, measured, and realized in behavioral healthcare.

Today, Carrie advises healthcare founders nationwide on growth, succession planning, and M&A strategy while leading the largest online outpatient behavioral health M&A community in the country, connecting more than 2,000 founders with capital and advisory services. She is currently focused on founder-aligned investment, acquisition, and partnership opportunities within healthcare services.

Ryan Kaczka is a seasoned private equity investor, investment banker, and operator with a specialization in initial public offerings, leveraged buyouts, mergers and acquisitions, and de-novo companies. With a primary focus on behavioral health, Ryan also spearheads investments in digital health, biotechnology, pharmaceuticals, and banking. With extensive experience in operations and leadership, he has served as CEO, COO, and board member of numerous companies. In 2018, he was recognized as the Tampa Spotlight CEO and named NJBIZ's 2023 Healthcare Innovator of the Year.

Mr. Kaczka is a prominent figure on various boards, including portfolio companies, the Rutgers University Center for Addiction Studies, the White House/ONDCP Opioid Litigation Abatement Advisory, an international bank, and an international healthcare non-profit. He also serves as a personal advisor to numerous federal, state, and local leaders, including Senators, Congressmen, Committees, Governors, and Department leaders. With a passion for Muay Thai fighting, astrophysics, and advocating for national healthcare and banking reform, Mr. Kaczka brings a unique perspective to his work in the field. His expertise and accomplishments make him the go-to choice for private equity and M&A expertise.

Dr. Britton's career journey in the mid-1990s began in the behavioral health sector, focusing on assisting patients with mental illness, substance use, and developmental disabilities. With a relentless pursuit of knowledge, Dr. Britton holds two master's degrees and a Doctorate in Public Health, specializing in executive leadership and strategy. His dedication and expertise propelled him to his first senior leadership position at the age of thirty-one. Over the past 24 years, he has overseen progressively larger organizations, notably serving as Division President of a prominent addiction treatment provider and holding four CEO positions in leading national behavioral health care organizations. In his most recent role as the owner and founder of Britton + Company Consulting, Dr. Britton serves as a partner to private equity-backed, privately held, and not-for-profit businesses. Britton + Company Consulting supports businesses in navigating the rapidly changing and dynamic landscape of healthcare, with a specialization in behavioral healthcare. Specifically, he partners with organizations to create and execute strategic plans that drive growth, profitability, and clinical excellence. Services include operational analysis, mergers and acquisition, talent management, strategic planning, and board support including operating partnerships.

Daniel Gemp is the Founder & Principal of Gempire Advisory and a successfully exited entrepreneur with nearly 20 years of experience in healthcare, technology, and growth strategy. He built and sold a national healthcare marketing agency, Dreamscape, that generated over $5B in client revenue via performance marketing. His work has led to hundreds of millions in M&A activity, completing two acquisitions of his agency in the process into what became the largest in the healthcare sector. Daniel advises executives, investors, and boards on scaling with AI-enabled business systems, blockchain, and advanced digital marketing, and is a frequent speaker at national conferences. He serves as a fractional Chief AI Officer at several innovative healthcare operators and will continue to expand his AI engagements and investments in the AI space.

Greg is a co-founder of Prosperity Behavioral Health with 15+ years of experience in finance and corporate strategy. He has assisted in the evaluation, execution and integration of multiple behavioral health M&A transactions while implementing plans for data-driven revenue cycle to help customers grow.